Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.

Saved in:
Bibliographic Details
Title: Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.
Authors: Wu JT; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Nowak E; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Imamura J; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA., Leng J; Case Western Reserve University School of Medicine, Cleveland, OH, USA., Shepard D; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Campbell SR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Scott J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Nystrom L; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA., Mesko N; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA., Schwartz GK; Case Comprehensive Cancer Center, Cleveland, OH, USA., Burke ZDC; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. burkez@ccf.org.; Genomic Medicine Institute, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. burkez@ccf.org.
Source: Current treatment options in oncology [Curr Treat Options Oncol] 2025 Oct; Vol. 26 (10), pp. 891-909. Date of Electronic Publication: 2025 Sep 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-6277
DOI:10.1007/s11864-025-01349-x